FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2072056392> ?p ?o ?g. }

• W2072056392 endingPage "4434" @default.
• W2072056392 startingPage "4434" @default.
• W2072056392 abstract "To investigate the effects of the somatostatin analogue, octreotide, on maltose and sucrase activities and expression of glucose transporter type 2 (GLUT2) in obese rat intestinal mucosa.We divided 49 Sprague-Dawley rats into a group of 31 high fat diet-induced obese rats and a group of 18 normal controls. The obese rats were separated into an octreotide treated group of 16 rats and an obese group of 15. The intervention group was injected with octreotide at 40 μg/kg body weight every 12 h for 8 d. Rat body weight was measured weekly to calculate Lee's index. After euthanization, maltase and sucrase activities in the small intestine were measured by activity assays, and the fasting plasma glucose level was measured. The expression of GLUT2 in small intestinal mucosa was analyzed by immunohistochemistry, reverse transcriptase polymerase chain reaction and Western blotting assays.Body weight, Lee's index, fasting plasma glucose level, maltase activity in small intestinal mucosa, mucosa and apical GLUT2, GLUT2 mRNA and protein expression levels were all significantly higher in the obese group than in the normal control group (605.61 ± 141.00 vs 378.54 ± 111.75, 337.61 ± 10.82 vs 318.73 ± 20.10, 8.60 ± 1.38 vs 7.33 ± 0.70, 156.01 ± 58.81 vs 50.43 ± 30.49, 390 744.2 ± 62 469.21 vs 170 546.50 ± 50 646.14, 26 740.18 ± 3809.60 vs 354.98 ± 57.19, 0.26 ± 0.11 vs 0.07 ± 0.02, and 2.08 ± 0.59 vs 1.27 ± 0.38, respectively, all P < 0.01). Sucrase activity did not differ between the two groups. Octreotide intervention significantly decreased the body weight and fasting plasma glucose level of obese rats (508.27 ± 94.39 vs 605.61 ± 141.00, 7.58 ± 1.51 vs 8.60 ±1.38, respectively, all P < 0.05). The intestinal mucosa and apical GLUT2, expression of GLUT2 mRNA and protein were also significantly lower in the octreotide intervention group than in the obese group (269 975.2 ± 53 730.94 vs 390 744.2 ± 62 469.21, 3758.06 ±364.51 vs 26 740.18 ± 3809.60, 0.08 ± 0.02 vs 0.26 ±0.11, and 1.31 ± 0.27 vs 2.08 ± 0.59, respectively, all P < 0.01).High fat diet-induced obesity is associated with elevated intestinal maltase activity, GLUT2 expression, and permanent apical GLUT2 in the small intestinal mucosa of rats. Octreotide can inhibit these effects." @default.
• W2072056392 created "2016-06-24" @default.
• W2072056392 creator A5005206049 @default.
• W2072056392 creator A5054901137 @default.
• W2072056392 creator A5061487237 @default.
• W2072056392 creator A5066245492 @default.
• W2072056392 creator A5066805347 @default.
• W2072056392 creator A5066820530 @default.
• W2072056392 creator A5067467878 @default.
• W2072056392 date "2011-01-01" @default.
• W2072056392 modified "2023-10-18" @default.
• W2072056392 title "Effects of octreotide on glucose transporter type 2 expression in obese rat small intestine" @default.
• W2072056392 cites W1756135944 @default.
• W2072056392 cites W1894212043 @default.
• W2072056392 cites W1976010697 @default.
• W2072056392 cites W1979875154 @default.
• W2072056392 cites W1980747853 @default.
• W2072056392 cites W1994090158 @default.
• W2072056392 cites W2000637330 @default.
• W2072056392 cites W2015207018 @default.
• W2072056392 cites W2033748201 @default.
• W2072056392 cites W2033849358 @default.
• W2072056392 cites W2040127137 @default.
• W2072056392 cites W2092834109 @default.
• W2072056392 cites W2099126367 @default.
• W2072056392 cites W2109132990 @default.
• W2072056392 cites W2111707331 @default.
• W2072056392 cites W2114095626 @default.
• W2072056392 cites W2122972388 @default.
• W2072056392 cites W2134948484 @default.
• W2072056392 cites W2147920556 @default.
• W2072056392 cites W2156587759 @default.
• W2072056392 cites W2168209643 @default.
• W2072056392 cites W2170826886 @default.
• W2072056392 cites W2174266219 @default.
• W2072056392 cites W2414344174 @default.
• W2072056392 cites W2414562428 @default.
• W2072056392 cites W33616521 @default.
• W2072056392 doi "https://doi.org/10.3748/wjg.v17.i39.4434" @default.
• W2072056392 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3218159" @default.
• W2072056392 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22110271" @default.
• W2072056392 hasPublicationYear "2011" @default.
• W2072056392 type Work @default.
• W2072056392 sameAs 2072056392 @default.
• W2072056392 citedByCount "9" @default.
• W2072056392 countsByYear W20720563922012 @default.
• W2072056392 countsByYear W20720563922013 @default.
• W2072056392 countsByYear W20720563922014 @default.
• W2072056392 countsByYear W20720563922015 @default.
• W2072056392 countsByYear W20720563922017 @default.
• W2072056392 countsByYear W20720563922019 @default.
• W2072056392 countsByYear W20720563922023 @default.
• W2072056392 crossrefType "journal-article" @default.
• W2072056392 hasAuthorship W2072056392A5005206049 @default.
• W2072056392 hasAuthorship W2072056392A5054901137 @default.
• W2072056392 hasAuthorship W2072056392A5061487237 @default.
• W2072056392 hasAuthorship W2072056392A5066245492 @default.
• W2072056392 hasAuthorship W2072056392A5066805347 @default.
• W2072056392 hasAuthorship W2072056392A5066820530 @default.
• W2072056392 hasAuthorship W2072056392A5067467878 @default.
• W2072056392 hasBestOaLocation W20720563921 @default.
• W2072056392 hasConcept C126322002 @default.
• W2072056392 hasConcept C134018914 @default.
• W2072056392 hasConcept C161573976 @default.
• W2072056392 hasConcept C181199279 @default.
• W2072056392 hasConcept C185592680 @default.
• W2072056392 hasConcept C2776039999 @default.
• W2072056392 hasConcept C2776297358 @default.
• W2072056392 hasConcept C2777882243 @default.
• W2072056392 hasConcept C2777901630 @default.
• W2072056392 hasConcept C2778649499 @default.
• W2072056392 hasConcept C2779306644 @default.
• W2072056392 hasConcept C2781025020 @default.
• W2072056392 hasConcept C3019368612 @default.
• W2072056392 hasConcept C55493867 @default.
• W2072056392 hasConcept C71924100 @default.
• W2072056392 hasConceptScore W2072056392C126322002 @default.
• W2072056392 hasConceptScore W2072056392C134018914 @default.
• W2072056392 hasConceptScore W2072056392C161573976 @default.
• W2072056392 hasConceptScore W2072056392C181199279 @default.
• W2072056392 hasConceptScore W2072056392C185592680 @default.
• W2072056392 hasConceptScore W2072056392C2776039999 @default.
• W2072056392 hasConceptScore W2072056392C2776297358 @default.
• W2072056392 hasConceptScore W2072056392C2777882243 @default.
• W2072056392 hasConceptScore W2072056392C2777901630 @default.
• W2072056392 hasConceptScore W2072056392C2778649499 @default.
• W2072056392 hasConceptScore W2072056392C2779306644 @default.
• W2072056392 hasConceptScore W2072056392C2781025020 @default.
• W2072056392 hasConceptScore W2072056392C3019368612 @default.
• W2072056392 hasConceptScore W2072056392C55493867 @default.
• W2072056392 hasConceptScore W2072056392C71924100 @default.
• W2072056392 hasIssue "39" @default.
• W2072056392 hasLocation W20720563921 @default.
• W2072056392 hasLocation W20720563922 @default.
• W2072056392 hasLocation W20720563923 @default.
• W2072056392 hasLocation W20720563924 @default.
• W2072056392 hasOpenAccess W2072056392 @default.
• W2072056392 hasPrimaryLocation W20720563921 @default.

• next